Modra Murovska

Modra Murovska, MD, PhD, (b. 1949) is a researcher in virology, medical microbiology, and molecular biology; the Director of A. Kirchenstein Institute of Microbiology and Virology, Riga Stradins University, Riga, Latvia; and an Associate Professor at Riga Stradins University, Riga, Latvia. She is a member of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME).

She is one of the authors of the 2011 case definition, International Consensus Criteria.

In 2009-2012, Dr. Murovska was assigned as Principle Investigator for the Latvian Council of Science in the investigation of etiopathogenesis of chronic fatigue syndrome, post-infection and unspecified origin encephalopathy and elaboration of diagnostic criterions.

Dr. Murovska chairs the Management Committee of the COST Action CA15111/EUROMENE and was the impetus to the program being started.

Education

 * 1972, MD, Riga Medical Institute /Medical Academy of Latvia/ (Faculty of Pediatrics)
 * 1978, Dr.med. (Candidate of Science in former USSR system, Ph.D. in Western countries), Cancer Research Centre, USSR Academy of Medical Sciences, Moscow, Russia

Studies

 * 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease (Full Text)
 * 2016, Occurrence, phase and status of human parvovirus B19 infection in patients with myalgic encephalomyelitis/chronic fatigue syndrome (Abstract)
 * 2014, No evidence of XMRV provirus sequences in patients with myalgic encephalomyelitis/chronic fatigue syndrome and individuals with unspecified encephalopathy (Full Text)
 * 2012, Association of active human herpesvirus-6, -7 and parvovirus B19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
 * 2006, Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome

Online Presence

 * Pubmed for Modra Murovska
 * Latvian Scientists webpage